FOXP3 and urogenital neoplasm: In kidney transplant recipients, studies have shown that recipients with higher levels of T-regulatory cells are less likely to experience allograft rejection, and that recipients with higher levels of FOXP3 show stable allograft function despite negligible immunosuppressive therapy (6).